Rocket Pharmaceuticals, Inc. · NASDAQ:RCKT
Stevens Christopher James sold 36,658 Rocket Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 11, 2026 · Filed Aug 13, 2026
On Aug 11, 2026, Stevens Christopher James (Chief Operating Officer) sold 36,658 Rocket Pharmaceuticals, Inc. shares at US$3.50 for US$128K, leaving 505,784 shares. Filed Aug 13, 2026 (Form 4).
- Sold
- 36,658 shares
- Price
- US$3.50
- Value
- US$128K
- Holding after
- 505,784 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Common Stock | Sale | 36,658 | US$3.50 | 505,784 | Direct |
Source
Related
- Rocket Pharmaceuticals, Inc.
- Stevens Christopher James
- Rocket Pharmaceuticals, Inc. shareholders
- Form 4 · Stevens Christopher James · Aug 5, 2026
- Form 4 · Wilson Martin · Sep 15, 2026
- Form 4 · Wilson Martin · Aug 20, 2026
- Form 4 · Shah Gaurav · Aug 20, 2026
- Form 4 · Shah Gaurav · Aug 17, 2026
- Form 4 · Wilson Martin · Aug 17, 2026